← Back to headlines
Analyst Predicts Significant Growth for CRISPR Therapeutics Stock
A top Wall Street analyst has issued a highly bullish forecast for CRISPR Therapeutics, suggesting the company's stock could more than double. The report encourages investors to consider a strong buy position.
11 May, 20:35 — 11 May, 20:35
Sources
Showing 1 of 1 sources
